Show simple item record

dc.contributor.authorConcepción Zavaleta, Marcio José
dc.contributor.authorCoronado-Arroyo, Julia Cristina
dc.contributor.authorQuiroz-Aldave, Juan
dc.contributor.authorDurand-Vásquez, María del Carmen
dc.contributor.authorIldefonso-Najarro, Sofía
dc.contributor.authorRafael-Robles, Luciana
dc.contributor.authorConcepción- Urteaga, Luis
dc.contributor.authorGamarra Osorio, Elman Rolando
dc.contributor.authorSuárez Rojas, Jacsel
dc.contributor.authorPaz-Ibarra, José
dc.date.accessioned2023-12-14T14:57:18Z
dc.date.available2023-12-14T14:57:18Z
dc.date.issued2023-09-04
dc.identifier.citationExpert Review of Endocrinology & Metabolism. 2023; 18(5).es_PE
dc.identifier.urihttps://hdl.handle.net/20.500.12959/4705
dc.description.abstractIntroduction: Infertility is defined as the inability to conceive after unprotected sexual intercourse for at least 12 consecutive months. Our objective is to present an updated narrative review on the endocrine causes of infertility in women. Areas covered: A comprehensive review was conducted using Scielo, Scopus, and EMBASE databases, comprising 245 articles. The pathophysiology of infertility in women was described, including endocrinopathies such as hypothalamic amenorrhea, hyperprolactinemia, polycystic ovary syndrome, primary ovarian insufficiency, obesity, thyroid dysfunction, and adrenal disorders. The diagnostic approach was outlined, emphasizing the necessity of hormonal studies and ovarian response assessments. Additionally, the treatment plan was presented, commencing with non-pharmacological interventions, encompassing the adoption of a Mediterranean diet, vitamin supplementation, moderate exercise, and maintaining a healthy weight. Subsequently, pharmacological treatment was discussed, focusing on the management of associated endocrine disorders and ovulatory dysfunction. Expert opinion: This comprehensive review highlights the impact of endocrine disorders on fertility in women, providing diagnostic and therapeutic algorithms. Despite remaining knowledge gaps that hinder more effective treatments, ongoing research and advancements show promise for improved fertility success rates within the next five years. Enhanced comprehension of the pathophysiology behind endocrine causes and the progress in genetic research will facilitate the delivery of personalized treatments, thus enhancing fertility rates.es_PE
dc.formatapplication/pdfes_PE
dc.language.isoenges_PE
dc.publisherTaylor & Francis Groupes_PE
dc.relation.urihttps://www.tandfonline.com/doi/full/10.1080/17446651.2023.2256405es_PE
dc.rightsinfo:eu-repo/semantics/openAccesses_PE
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/es_PE
dc.subjectFertilityes_PE
dc.subjectFemale infertilityes_PE
dc.subjectAnovulationes_PE
dc.subjectReproductive healthes_PE
dc.subjectOvarian reservees_PE
dc.subjectHormoneses_PE
dc.titleEndocrine factors associated with infertility in women: an updated reviewes_PE
dc.typeinfo:eu-repo/semantics/articlees_PE
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.18es_PE
dc.identifier.doihttps://doi.org/10.1080/17446651.2023.2256405


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess

El repositorio recopila la documentación y publicaciones institucionales, producto de la investigación y el desempeño en defensa de la competencia, la propiedad intelectual y protección al consumidor, para su difusión en el entorno social y académico. Se difunde en acceso abierto y está alineado con las Declaraciones de Budapest y de Berlín.

Contactos